Clinical Trial

Predictive Role of sTREM in Endovascular Thrombectomy Outcomes

Name: Predictive Role of sTREM in Endovascular Thrombectomy Outcomes — clinical trial record (NCT06545591)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Soluble triggering receptor expressed on myeloid cells (sTREM), which reflects microglia activation, has been reported closely associated with neuronal injury and neuroinflammation. This study is to investigatethe prognostic roles of sTREM (sTREM1 and sTREM2) in patients with ischemic stroke who underwent endovascular thrombectomy (EVT).

Trial Details

NCT Number	NCT06545591
Lead Sponsor	The Affiliated Hospital of Xuzhou Medical University
Conditions	Acute Ischemic Stroke
Enrollment	300 participants
Start Date	2024-07-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-08-09